Enterprise Value
65.31M
Cash
144.9M
Avg Qtr Burn
-26.14M
Short % of Float
40.63%
Insider Ownership
25.14%
Institutional Own.
76.58%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
BMF-219 Details Type 1 diabetes | Phase 2 Update | |
BMF-219 Details Non-small cell lung carcinoma, Colorectal cancer , Pancreatic cancer, Solid tumor/s | Phase 1/2 Data readout | |
BMF-219 Details Type 2 diabetes | Phase 1/2 Update | |
BMF-500 Details Leukemia | Phase 1 Data readout | |
BMF-219 Details Acute myeloid leukemia, Acute lymphoblastic leukemia | Phase 1 Update |